| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.832 | 0.003 | 0.843 | 5 Hydroxytryptamine release stimulant | 0.843 0.003 CID_10257 | CID_10257 | |
| 0.743 | 0.002 | 0.743 | 5 Hydroxytryptamine 1E antagonist | 0.708 0.002 CID_10257 | ||
| 0.684 | 0.004 | 0.684 | 5 Hydroxytryptamine 1 agonist | 0.645 0.004 CID_10257 | ||
| 0.655 | 0.002 | 0.655 | 5 Hydroxytryptamine 5 antagonist | 0.509 0.003 CID_10257 | ||
| 0.643 | 0.002 | 0.643 | 5 Hydroxytryptamine 1D antagonist | 0.475 0.003 CID_10257 | ||
| 0.636 | 0.002 | 0.636 | 5 Hydroxytryptamine 5A antagonist | 0.539 0.003 CID_10257 | ||
| 0.66 | 0.029 | 0.66 | Caspase 9 stimulant | 0.604 0.036 CID_10257 | ||
| 0.595 | 0.004 | 0.595 | 5 Hydroxytryptamine agonist | 0.539 0.004 CID_10257 | ||
| 0.59 | 0.004 | 0.59 | 5 Hydroxytryptamine 1 antagonist | 0.372 0.007 CID_10257 | ||
| 0.57 | 0.005 | 0.57 | 5 Hydroxytryptamine antagonist | 0.342 0.015 CID_10257 | ||
| 0.558 | 0.007 | 0.576 | Psychostimulant | 0.576 0.007 CID_10257 | CID_10257 | |
| 0.545 | 0.003 | 0.545 | 5 Hydroxytryptamine 1B antagonist | 0.402 0.004 CID_10257 | ||
| 0.509 | 0.004 | 0.509 | 5 Hydroxytryptamine 2C antagonist | 0.3 0.009 CID_10257 | ||
| 0.502 | 0.004 | 0.502 | 5 Hydroxytryptamine 1F antagonist | 0.478 0.004 CID_10257 | ||
| 0.482 | 0.001 | 0.482 | 5 Hydroxytryptamine 3E antagonist | 0.463 0.002 CID_10257 | ||
| 0.485 | 0.005 | 0.485 | 5 Hydroxytryptamine 2B antagonist | 0.345 0.012 CID_10257 | ||
| 0.479 | 0.005 | 0.479 | 5 Hydroxytryptamine 1A antagonist | 0.27 0.01 CID_10257 | ||
| 0.472 | 0.002 | 0.472 | 5 Hydroxytryptamine 7 agonist | 0.304 0.003 CID_10257 | ||
| 0.469 | 0.004 | 0.469 | Alpha 2b adrenoreceptor antagonist | 0.376 0.005 CID_10257 | ||
| 0.456 | 0.007 | 0.456 | 5 Hydroxytryptamine 2 antagonist | 0.295 0.017 CID_10257 | ||
| 0.477 | 0.033 | 0.477 | Vasodilator, peripheral | 0.468 0.035 CID_10257 | ||
| 0.441 | 0.003 | 0.442 | 5 Hydroxytryptamine 1B agonist | 0.442 0.003 CID_10257 | CID_10257 | |
| 0.456 | 0.047 | 0.509 | Calcium channel L-type activator | 0.509 0.024 CID_10257 | CID_10257 | |
| 0.453 | 0.06 | 0.453 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.449 0.062 CID_10257 | ||
| 0.399 | 0.007 | 0.399 | 5 Hydroxytryptamine 2A antagonist | 0.242 0.015 CID_10257 | ||
| 0.412 | 0.029 | 0.49 | Interleukin antagonist | 0.49 0.021 CID_10257 | CID_10257 | |
| 0.377 | 0.003 | 0.377 | 5 Hydroxytryptamine 2A agonist | 0.313 0.003 CID_10257 | ||
| 0.377 | 0.003 | 0.436 | Myeloperoxidase inhibitor | 0.436 0.003 CID_10257 | CID_10257 | |
| 0.391 | 0.026 | 0.449 | Amyloid beta aggregation inhibitor | 0.449 0.019 CID_10257 | CID_10257 | |
| 0.397 | 0.036 | 0.397 | Vasodilator, coronary | 0.363 0.049 CID_10257 | ||
| 0.385 | 0.03 | 0.385 | Calcium channel activator | 0.334 0.062 CID_10257 | ||
| 0.4 | 0.047 | 0.59 | Aldehyde oxidase inhibitor | 0.59 0.02 CID_10257 | CID_10257 | |
| 0.347 | 0.003 | 0.456 | Histamine N-methyltransferase inhibitor | 0.456 0.002 CID_10257 | CID_10257 | |
| 0.364 | 0.029 | 0.412 | Insulysin inhibitor | 0.412 0.02 CID_10257 | CID_10257 | |
| 0.338 | 0.005 | 0.338 | Alpha 2c adrenoreceptor antagonist | 0.259 0.009 CID_10257 | ||
| 0.353 | 0.03 | 0.353 | Sigma receptor agonist | 0.328 0.034 CID_10257 | ||
| 0.324 | 0.002 | 0.324 | 5 Hydroxytryptamine 1D agonist | 0.264 0.002 CID_10257 | ||
| 0.324 | 0.003 | 0.426 | Prolactin inhibitor | 0.426 0.002 CID_10257 | CID_10257 | |
| 0.382 | 0.07 | 0.545 | GABA C receptor rho-3 antagonist | 0.545 0.015 CID_10257 | CID_10257 | |
| 0.357 | 0.05 | 0.4 | Spasmolytic | 0.4 0.04 CID_10257 | CID_10257 | |
| 0.342 | 0.039 | 0.351 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.351 0.036 CID_10257 | CID_10257 | |
| 0.298 | 0.001 | 0.298 | Melatonin receptor 1A agonist | 0.103 0.003 CID_10257 | ||
| 0.337 | 0.045 | 0.344 | DNA damaging | 0.344 0.043 CID_10257 | CID_10257 | |
| 0.299 | 0.016 | 0.299 | Alpha adrenoreceptor antagonist | 0.178 0.031 CID_10257 | ||
| 0.323 | 0.055 | 0.323 | Aryl hydrocarbon receptor agonist | 0.271 0.071 CID_10257 | ||
| 0.275 | 0.009 | 0.275 | Alpha 2 adrenoreceptor antagonist | 0.211 0.016 CID_10257 | ||
| 0.312 | 0.048 | 0.325 | Antiamyloidogenic | 0.325 0.045 CID_10257 | CID_10257 | |
| 0.293 | 0.03 | 0.294 | DNA methylase inhibitor | 0.294 0.03 CID_10257 | CID_10257 | |
| 0.278 | 0.025 | 0.3 | Lipocortins synthesis antagonist | 0.3 0.021 CID_10257 | CID_10257 | |
| 0.271 | 0.021 | 0.292 | Nitric-oxide synthase stimulant | 0.292 0.013 CID_10257 | CID_10257 | |
| 0.283 | 0.033 | 0.285 | DNA methyltransferase I inhibitor | 0.285 0.032 CID_10257 | CID_10257 | |
| 0.252 | 0.005 | 0.283 | 5 Hydroxytryptamine 3A agonist | 0.283 0.004 CID_10257 | CID_10257 | |
| 0.254 | 0.009 | 0.254 | Alpha 2a adrenoreceptor antagonist | 0.213 0.012 CID_10257 | ||
| 0.345 | 0.102 | 0.438 | Histamine release inhibitor | 0.438 0.056 CID_10257 | CID_10257 | |
| 0.345 | 0.102 | 0.426 | 15-Lipoxygenase inhibitor | 0.426 0.063 CID_10257 | CID_10257 | |
| 0.246 | 0.004 | 0.246 | 5 Hydroxytryptamine 2 agonist | 0.157 0.005 CID_10257 | ||
| 0.287 | 0.047 | 0.287 | Cyclic AMP phosphodiesterase inhibitor | 0.287 0.047 CID_10257 | ||
| 0.243 | 0.007 | 0.268 | CF transmembrane conductance regulator agonist | 0.268 0.005 CID_10257 | CID_10257 | |
| 0.244 | 0.01 | 0.244 | Nav1.6 sodium channel blocker | 0.199 0.019 CID_10257 | ||
| 0.241 | 0.014 | 0.265 | GABA C receptor rho-2 antagonist | 0.265 0.009 CID_10257 | CID_10257 | |
| 0.233 | 0.012 | 0.233 | Alpha 1b adrenoreceptor antagonist | 0.15 0.022 CID_10257 | ||
| 0.237 | 0.016 | 0.237 | Alpha 1 adrenoreceptor antagonist | 0.123 0.036 CID_10257 | ||
| 0.243 | 0.023 | 0.243 | Nav1.2 sodium channel blocker | 0.208 0.032 CID_10257 | ||
| 0.288 | 0.071 | 0.305 | Hypoxia-inducible factor 1 alpha inhibitor | 0.305 0.063 CID_10257 | CID_10257 | |
| 0.225 | 0.009 | 0.225 | 5 Hydroxytryptamine uptake inhibitor | 0.183 0.013 CID_10257 | ||
| 0.222 | 0.012 | 0.222 | Falcipain 3 inhibitor | 0.208 0.015 CID_10257 | ||
| 0.213 | 0.004 | 0.213 | 5 Hydroxytryptamine 6 antagonist | 0.148 0.006 CID_10257 | ||
| 0.23 | 0.025 | 0.267 | Neurotensin receptor agonist | 0.267 0.018 CID_10257 | CID_10257 | |
| 0.213 | 0.011 | 0.213 | 5 Hydroxytryptamine 7 antagonist | 0.155 0.017 CID_10257 | ||
| 0.212 | 0.012 | 0.254 | Protein kinase C gamma inhibitor | 0.254 0.006 CID_10257 | CID_10257 | |
| 0.217 | 0.029 | 0.239 | NADPH oxidase inhibitor | 0.239 0.023 CID_10257 | CID_10257 | |
| 0.212 | 0.027 | 0.227 | MAO A inhibitor | 0.227 0.024 CID_10257 | CID_10257 | |
| 0.246 | 0.063 | 0.263 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.263 0.054 CID_10257 | CID_10257 | |
| 0.202 | 0.021 | 0.202 | Butyrylcholinesterase inhibitor | 0.156 0.032 CID_10257 | ||
| 0.255 | 0.079 | 0.255 | Cardiotonic | 0.229 0.096 CID_10257 | ||
| 0.186 | 0.011 | 0.186 | Alpha 1d adrenoreceptor antagonist | 0.1 0.023 CID_10257 | ||
| 0.204 | 0.032 | 0.204 | Acetylcholinesterase inhibitor | 0.16 0.049 CID_10257 | ||
| 0.188 | 0.018 | 0.188 | Alpha 1a adrenoreceptor antagonist | 0.096 0.038 CID_10257 | ||
| 0.188 | 0.018 | 0.188 | Dopamine D2 antagonist | 0.143 0.024 CID_10257 | ||
| 0.174 | 0.005 | 0.231 | Beta 3 adrenoreceptor antagonist | 0.231 0.004 CID_10257 | CID_10257 | |
| 0.189 | 0.02 | 0.236 | Adenylate cyclase stimulant | 0.236 0.005 CID_10257 | CID_10257 | |
| 0.188 | 0.02 | 0.188 | Dopamine antagonist | 0.153 0.025 CID_10257 | ||
| 0.172 | 0.004 | 0.172 | Melatonin agonist | 0.075 0.005 CID_10257 | ||
| 0.21 | 0.043 | 0.24 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.24 0.034 CID_10257 | CID_10257 | |
| 0.23 | 0.063 | 0.286 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.286 0.047 CID_10257 | CID_10257 | |
| 0.168 | 0.009 | 0.168 | Acetylcholine release stimulant | 0.127 0.037 CID_10257 | ||
| 0.176 | 0.017 | 0.176 | Calcium antagonist | |||
| 0.196 | 0.037 | 0.196 | Toll-Like receptor 9 antagonist | 0.133 0.075 CID_10257 | ||
| 0.187 | 0.029 | 0.202 | DNA intercalator | 0.202 0.025 CID_10257 | CID_10257 | |
| 0.238 | 0.081 | 0.238 | Tumour necrosis factor alpha release inhibitor | 0.175 0.13 CID_10257 | ||
| 0.166 | 0.017 | 0.256 | Protein kinase C zeta inhibitor | 0.256 0.007 CID_10257 | CID_10257 | |
| 0.197 | 0.048 | 0.197 | Cholinergic | 0.149 0.077 CID_10257 | ||
| 0.208 | 0.063 | 0.208 | Focal adhesion kinase 2 inhibitor | |||
| 0.156 | 0.01 | 0.156 | 5 Hydroxytryptamine 1A agonist | 0.098 0.016 CID_10257 | ||
| 0.176 | 0.032 | 0.29 | Adenylate cyclase inhibitor | 0.29 0.014 CID_10257 | CID_10257 | |
| 0.165 | 0.023 | 0.195 | Antineoplastic alkaloid | 0.195 0.015 CID_10257 | CID_10257 | |
| 0.197 | 0.055 | 0.197 | Tumour necrosis factor antagonist | |||
| 0.145 | 0.005 | 0.19 | 5 Hydroxytryptamine 3 agonist | 0.19 0.004 CID_10257 | CID_10257 | |
| 0.236 | 0.096 | 0.239 | Gastrin inhibitor | 0.239 0.093 CID_10257 | CID_10257 | |
| 0.169 | 0.031 | 0.169 | Antiadrenergic | 0.144 0.038 CID_10257 | ||
| 0.182 | 0.047 | 0.183 | MAO inhibitor | 0.183 0.046 CID_10257 | CID_10257 | |
| 0.164 | 0.031 | 0.164 | Adrenaline antagonist | 0.139 0.038 CID_10257 | ||
| 0.151 | 0.02 | 0.151 | Acetylcholine nicotinic antagonist | 0.143 0.022 CID_10257 | ||
| 0.17 | 0.039 | 0.206 | Toll-Like receptor 2 antagonist | 0.206 0.021 CID_10257 | CID_10257 | |
| 0.175 | 0.047 | 0.175 | Tubulin antagonist | |||
| 0.176 | 0.054 | 0.223 | Acetylcholine M1 receptor antagonist | 0.223 0.033 CID_10257 | CID_10257 | |
| 0.123 | 0.002 | 0.123 | 5 Hydroxytryptamine 6 agonist | 0.116 0.002 CID_10257 | ||
| 0.221 | 0.101 | 0.315 | Tyrosine 3 hydroxylase inhibitor | 0.315 0.026 CID_10257 | CID_10257 | |
| 0.145 | 0.027 | 0.145 | Sphingomyelinase inhibitor | 0.1 0.059 CID_10257 | ||
| 0.16 | 0.042 | 0.16 | Nav1.3 sodium channel blocker | 0.125 0.069 CID_10257 | ||
| 0.165 | 0.047 | 0.18 | Neurotrophic factor | 0.18 0.038 CID_10257 | CID_10257 | |
| 0.132 | 0.015 | 0.132 | Neuronal nicotinic receptor antagonist | 0.123 0.017 CID_10257 | ||
| 0.121 | 0.004 | 0.121 | Melatonin 1 agonist | 0.073 0.005 CID_10257 | ||
| 0.189 | 0.074 | 0.198 | Growth factor agonist | 0.198 0.065 CID_10257 | CID_10257 | |
| 0.147 | 0.033 | 0.16 | Photosensitizer | 0.16 0.025 CID_10257 | CID_10257 | |
| 0.134 | 0.021 | 0.136 | CYP2A6 inhibitor | 0.136 0.02 CID_10257 | CID_10257 | |
| 0.29 | 0.179 | 0.318 | Apoptosis agonist | 0.318 0.16 CID_10257 | CID_10257 | |
| 0.131 | 0.021 | 0.215 | Adrenaline agonist | 0.215 0.005 CID_10257 | CID_10257 | |
| 0.16 | 0.049 | 0.16 | Toll-Like receptor antagonist | 0.148 0.057 CID_10257 | ||
| 0.151 | 0.043 | 0.163 | Heat shock protein 70 antagonist | 0.163 0.024 CID_10257 | CID_10257 | |
| 0.126 | 0.019 | 0.126 | Dopamine D3 antagonist | 0.091 0.028 CID_10257 | ||
| 0.111 | 0.004 | 0.111 | Melatonin antagonist | 0.045 0.009 CID_10257 | ||
| 0.127 | 0.021 | 0.163 | Somatostatin 1 agonist | 0.163 0.011 CID_10257 | CID_10257 | |
| 0.173 | 0.068 | 0.466 | Peroxidase inhibitor | 0.466 0.013 CID_10257 | CID_10257 | |
| 0.114 | 0.01 | 0.114 | Nicotinic receptor alpha7 subunit antagonist | 0.098 0.013 CID_10257 | ||
| 0.137 | 0.033 | 0.137 | Gastric antisecretory | 0.109 0.055 CID_10257 | ||
| 0.105 | 0.003 | 0.105 | Melatonin receptor 1A antagonist | |||
| 0.107 | 0.005 | 0.107 | Calcium channel P-type blocker | 0.066 0.038 CID_10257 | ||
| 0.176 | 0.076 | 0.192 | LIM domain kinase 1 inhibitor | 0.192 0.067 CID_10257 | CID_10257 | |
| 0.125 | 0.026 | 0.125 | Toll-Like receptor 3 antagonist | 0.085 0.081 CID_10257 | ||
| 0.194 | 0.096 | 0.194 | ErbB-1 antagonist | 0.183 0.11 CID_10257 | ||
| 0.103 | 0.005 | 0.103 | 5 Hydroxytryptamine 3B antagonist | 0.083 0.006 CID_10257 | ||
| 0.104 | 0.007 | 0.104 | Cyclin D1 inhibitor | 0.083 0.016 CID_10257 | ||
| 0.108 | 0.012 | 0.135 | GABA B receptor agonist | 0.135 0.005 CID_10257 | CID_10257 | |
| 0.266 | 0.17 | 0.266 | MAP kinase kinase 6 inhibitor | 0.26 0.178 CID_10257 | ||
| 0.111 | 0.015 | 0.139 | Estrogen-related receptor beta agonist | 0.139 0.005 CID_10257 | CID_10257 | |
| 0.145 | 0.05 | 0.145 | Antibacterial (Helicobacter pylori) | 0.141 0.054 CID_10257 | ||
| 0.118 | 0.022 | 0.128 | Alpha adrenoreceptor agonist | 0.128 0.02 CID_10257 | CID_10257 | |
| 0.2 | 0.105 | 0.22 | Vasodilator | 0.22 0.09 CID_10257 | CID_10257 | |
| 0.115 | 0.021 | 0.142 | Glycine receptor antagonist | 0.142 0.009 CID_10257 | CID_10257 | |
| 0.099 | 0.004 | 0.104 | Adenylate cyclase 1 inhibitor | 0.104 0.004 CID_10257 | CID_10257 | |
| 0.097 | 0.005 | 0.097 | Melatonin 2 agonist | 0.058 0.008 CID_10257 | ||
| 0.185 | 0.093 | 0.185 | Antimitotic | |||
| 0.182 | 0.092 | 0.204 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.204 0.073 CID_10257 | CID_10257 | |
| 0.134 | 0.045 | 0.134 | GABA receptor agonist | 0.131 0.048 CID_10257 | ||
| 0.11 | 0.022 | 0.11 | Acetylcholine M4 receptor antagonist | 0.087 0.04 CID_10257 | ||
| 0.183 | 0.095 | 0.183 | Platelet aggregation inhibitor | |||
| 0.092 | 0.004 | 0.113 | Dopamine autoreceptor agonist | 0.113 0.004 CID_10257 | CID_10257 | |
| 0.124 | 0.037 | 0.124 | Breast cancer-resistant protein inhibitor | 0.086 0.07 CID_10257 | ||
| 0.104 | 0.017 | 0.104 | Bombesin 1 receptor agonist | 0.1 0.018 CID_10257 | ||
| 0.124 | 0.037 | 0.166 | GABA C receptor rho-1 antagonist | 0.166 0.015 CID_10257 | CID_10257 | |
| 0.101 | 0.016 | 0.123 | Beta adrenoreceptor antagonist | 0.123 0.01 CID_10257 | CID_10257 | |
| 0.108 | 0.024 | 0.147 | Dopamine agonist | 0.147 0.015 CID_10257 | CID_10257 | |
| 0.164 | 0.081 | 0.192 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.192 0.068 CID_10257 | CID_10257 | |
| 0.12 | 0.038 | 0.12 | Nitric-oxide synthase inhibitor | 0.115 0.041 CID_10257 | ||
| 0.1 | 0.017 | 0.1 | 5 Hydroxytryptamine 3 antagonist | 0.061 0.034 CID_10257 | ||
| 0.106 | 0.024 | 0.106 | Dopamine D4 antagonist | 0.073 0.035 CID_10257 | ||
| 0.178 | 0.096 | 0.211 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.211 0.064 CID_10257 | CID_10257 | |
| 0.127 | 0.046 | 0.209 | GABA C receptor antagonist | 0.209 0.011 CID_10257 | CID_10257 | |
| 0.093 | 0.012 | 0.11 | Beta 1 adrenoreceptor antagonist | 0.11 0.008 CID_10257 | CID_10257 | |
| 0.143 | 0.063 | 0.143 | Interleukin 1 antagonist | 0.121 0.087 CID_10257 | ||
| 0.09 | 0.01 | 0.097 | Cholecystokinin A antagonist | 0.097 0.009 CID_10257 | CID_10257 | |
| 0.089 | 0.01 | 0.089 | 5 Hydroxytryptamine 4 antagonist | 0.061 0.023 CID_10257 | ||
| 0.102 | 0.024 | 0.157 | Dopamine D1 antagonist | 0.157 0.014 CID_10257 | CID_10257 | |
| 0.106 | 0.03 | 0.106 | Histamine H2 receptor antagonist | 0.088 0.051 CID_10257 | ||
| 0.092 | 0.017 | 0.092 | Aryl hydrocarbon receptor antagonist | 0.084 0.023 CID_10257 | ||
| 0.126 | 0.052 | 0.178 | Topoisomerase I inhibitor | 0.178 0.032 CID_10257 | CID_10257 | |
| 0.094 | 0.02 | 0.094 | 5 Hydroxytryptamine 3A antagonist | 0.065 0.048 CID_10257 | ||
| 0.092 | 0.019 | 0.092 | Alpha 1 adrenoreceptor agonist | 0.07 0.028 CID_10257 | ||
| 0.183 | 0.111 | 0.288 | Free radical scavenger | 0.288 0.055 CID_10257 | CID_10257 | |
| 0.109 | 0.037 | 0.119 | Phosphodiesterase 6D inhibitor | 0.119 0.026 CID_10257 | CID_10257 | |
| 0.098 | 0.027 | 0.098 | Benzodiazepine agonist | 0.066 0.057 CID_10257 | ||
| 0.077 | 0.005 | 0.077 | Sigma 2 receptor antagonist | 0.07 0.006 CID_10257 | ||
| 0.197 | 0.125 | 0.229 | Neuropeptide Y2 antagonist | 0.229 0.078 CID_10257 | CID_10257 | |
| 0.08 | 0.011 | 0.09 | Cholecystokinin antagonist | 0.09 0.009 CID_10257 | CID_10257 | |
| 0.073 | 0.005 | 0.073 | 5 Hydroxytryptamine 2B agonist | 0.051 0.013 CID_10257 | ||
| 0.141 | 0.073 | 0.141 | Vascular endothelial growth factor 3 antagonist | |||
| 0.132 | 0.064 | 0.162 | Cholinergic antagonist | 0.162 0.046 CID_10257 | CID_10257 | |
| 0.165 | 0.098 | 0.165 | MAP kinase kinase 5 inhibitor | |||
| 0.119 | 0.053 | 0.154 | Nav1.4 sodium channel blocker | 0.154 0.032 CID_10257 | CID_10257 | |
| 0.206 | 0.14 | 0.223 | 5 Hydroxytryptamine uptake stimulant | 0.223 0.112 CID_10257 | CID_10257 | |
| 0.104 | 0.038 | 0.104 | Platelet growth factor antagonist | |||
| 0.115 | 0.049 | 0.115 | Platelet activating factor alpha antagonist | |||
| 0.072 | 0.006 | 0.072 | Benzodiazepine antagonist | 0.046 0.035 CID_10257 | ||
| 0.086 | 0.022 | 0.098 | Acetylcholine M5 receptor antagonist | 0.098 0.018 CID_10257 | CID_10257 | |
| 0.069 | 0.004 | 0.069 | Melatonin 1 antagonist | 0.023 0.009 CID_10257 | ||
| 0.145 | 0.081 | 0.148 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.148 0.076 CID_10257 | CID_10257 | |
| 0.072 | 0.009 | 0.072 | GHS receptor agonist | 0.067 0.01 CID_10257 | ||
| 0.127 | 0.065 | 0.155 | Acetylcholine antagonist | 0.155 0.047 CID_10257 | CID_10257 | |
| 0.076 | 0.015 | 0.121 | Dopamine D2 agonist | 0.121 0.008 CID_10257 | CID_10257 | |
| 0.073 | 0.012 | 0.08 | Histone deacetylase 7 inhibitor | 0.08 0.011 CID_10257 | CID_10257 | |
| 0.124 | 0.064 | 0.124 | Beta amyloid protein antagonist | |||
| 0.078 | 0.019 | 0.083 | Gonadotropin-releasing hormone receptor agonist | 0.083 0.016 CID_10257 | CID_10257 | |
| 0.168 | 0.11 | 0.181 | Insulin sensitizer | 0.181 0.094 CID_10257 | CID_10257 | |
| 0.1 | 0.041 | 0.1 | Histamine H1 receptor antagonist | 0.087 0.051 CID_10257 | ||
| 0.111 | 0.054 | 0.128 | Urease inhibitor | 0.128 0.037 CID_10257 | CID_10257 | |
| 0.061 | 0.005 | 0.061 | Follicle-stimulating hormone agonist | 0.045 0.007 CID_10257 | ||
| 0.063 | 0.007 | 0.067 | Bombesin 1 receptor antagonist | 0.067 0.005 CID_10257 | CID_10257 | |
| 0.061 | 0.005 | 0.066 | Urotensin II agonist | 0.066 0.004 CID_10257 | CID_10257 | |
| 0.109 | 0.053 | 0.18 | Carbonic anhydrase III inhibitor | 0.18 0.02 CID_10257 | CID_10257 | |
| 0.072 | 0.019 | 0.08 | Prolactin release inhibitor | 0.08 0.011 CID_10257 | CID_10257 | |
| 0.07 | 0.017 | 0.098 | Beta 2 adrenoreceptor antagonist | 0.098 0.008 CID_10257 | CID_10257 | |
| 0.143 | 0.091 | 0.164 | Melanin inhibitor | 0.164 0.065 CID_10257 | CID_10257 | |
| 0.136 | 0.084 | 0.14 | MAP3K9 inhibitor | 0.14 0.076 CID_10257 | CID_10257 | |
| 0.065 | 0.016 | 0.069 | Immunoglobulin Fc receptor antagonist | 0.069 0.012 CID_10257 | CID_10257 | |
| 0.107 | 0.058 | 0.129 | Carbonic anhydrase XV inhibitor | 0.129 0.04 CID_10257 | CID_10257 | |
| 0.061 | 0.012 | 0.061 | Substance P antagonist | 0.047 0.019 CID_10257 | ||
| 0.068 | 0.021 | 0.068 | Histamine agonist | 0.053 0.036 CID_10257 | ||
| 0.051 | 0.005 | 0.053 | 5 Hydroxytryptamine 1F agonist | 0.053 0.005 CID_10257 | CID_10257 | |
| 0.131 | 0.085 | 0.131 | CDC-like kinase 1 inhibitor | 0.111 0.105 CID_10257 | ||
| 0.092 | 0.046 | 0.092 | GABA A receptor agonist | 0.081 0.061 CID_10257 | ||
| 0.126 | 0.081 | 0.126 | Calcium channel blocker | |||
| 0.057 | 0.013 | 0.07 | Histone deacetylase 9 inhibitor | 0.07 0.009 CID_10257 | CID_10257 | |
| 0.057 | 0.013 | 0.092 | Somatostatin 4 agonist | 0.092 0.007 CID_10257 | CID_10257 | |
| 0.098 | 0.054 | 0.129 | Protein kinase C delta inhibitor | 0.129 0.032 CID_10257 | CID_10257 | |
| 0.205 | 0.161 | 0.205 | Caspase 3 stimulant | 0.192 0.182 CID_10257 | ||
| 0.112 | 0.069 | 0.112 | Platelet activating factor antagonist | |||
| 0.075 | 0.034 | 0.075 | Potassium channel (ATP-sensitive) blocker | 0.063 0.055 CID_10257 | ||
| 0.057 | 0.016 | 0.057 | Histamine H2 receptor agonist | 0.052 0.02 CID_10257 | ||
| 0.102 | 0.062 | 0.102 | Bronchodilator | 0.097 0.067 CID_10257 | ||
| 0.063 | 0.024 | 0.063 | Neurokinin antagonist | 0.053 0.03 CID_10257 | ||
| 0.086 | 0.047 | 0.121 | CC chemokine 5 receptor agonist | 0.121 0.008 CID_10257 | CID_10257 | |
| 0.066 | 0.028 | 0.086 | Beta 2 adrenoreceptor agonist | 0.086 0.006 CID_10257 | CID_10257 | |
| 0.054 | 0.016 | 0.054 | Growth hormone secretagogue receptor antagonist | 0.035 0.024 CID_10257 | ||
| 0.137 | 0.099 | 0.19 | Growth hormone agonist | 0.19 0.063 CID_10257 | CID_10257 | |
| 0.206 | 0.17 | 0.253 | Antithrombotic | 0.253 0.123 CID_10257 | CID_10257 | |
| 0.073 | 0.038 | 0.073 | Fibroblast growth factor 2 antagonist | |||
| 0.044 | 0.009 | 0.044 | GHS receptor antagonist | 0.038 0.014 CID_10257 | ||
| 0.048 | 0.014 | 0.086 | Somatostatin agonist | 0.086 0.009 CID_10257 | CID_10257 | |
| 0.052 | 0.019 | 0.069 | Somatostatin 1 antagonist | 0.069 0.012 CID_10257 | CID_10257 | |
| 0.05 | 0.018 | 0.05 | Histamine H1 receptor agonist | 0.05 0.018 CID_10257 | ||
| 0.11 | 0.077 | 0.164 | Interleukin 8 antagonist | 0.164 0.026 CID_10257 | CID_10257 | |
| 0.055 | 0.023 | 0.059 | Bombesin antagonist | 0.059 0.019 CID_10257 | CID_10257 | |
| 0.077 | 0.046 | 0.077 | Phosphodiesterase VI inhibitor | |||
| 0.079 | 0.049 | 0.079 | MAP kinase 7 inhibitor | |||
| 0.034 | 0.004 | 0.034 | Follicle-stimulating hormone antagonist | 0.03 0.005 CID_10257 | ||
| 0.106 | 0.077 | 0.106 | Anesthetic local | 0.095 0.088 CID_10257 | ||
| 0.052 | 0.023 | 0.052 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.087 | 0.058 | 0.087 | Insulin growth factor antagonist | |||
| 0.062 | 0.034 | 0.062 | Protein kinase C theta inhibitor | 0.06 0.036 CID_10257 | ||
| 0.056 | 0.028 | 0.056 | Alpha 1L adrenoreceptor antagonist | |||
| 0.103 | 0.075 | 0.103 | Electron transport complex I inhibitor | |||
| 0.092 | 0.065 | 0.092 | Alpha 2d adrenoreceptor antagonist | 0.088 0.076 CID_10257 | ||
| 0.061 | 0.035 | 0.061 | Ryanodine receptor antagonist | |||
| 0.154 | 0.127 | 0.154 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.098 | 0.072 | 0.132 | Beta glucuronidase inhibitor | 0.132 0.035 CID_10257 | CID_10257 | |
| 0.029 | 0.003 | 0.029 | Melatonin 2 antagonist | |||
| 0.09 | 0.064 | 0.09 | Antihistaminic | |||
| 0.056 | 0.03 | 0.059 | Sigma receptor antagonist | 0.059 0.029 CID_10257 | CID_10257 | |
| 0.04 | 0.014 | 0.048 | Cholecystokinin B antagonist | 0.048 0.011 CID_10257 | CID_10257 | |
| 0.098 | 0.073 | 0.137 | AMP-activated protein kinase stimulant | 0.137 0.036 CID_10257 | CID_10257 | |
| 0.082 | 0.058 | 0.082 | Insulin like growth factor 1 antagonist | |||
| 0.053 | 0.03 | 0.061 | Bombesin 2 receptor antagonist | 0.061 0.023 CID_10257 | CID_10257 | |
| 0.062 | 0.04 | 0.076 | Alpha 2 adrenoreceptor agonist | 0.076 0.026 CID_10257 | CID_10257 | |
| 0.047 | 0.025 | 0.067 | Beta adrenoreceptor agonist | 0.067 0.006 CID_10257 | CID_10257 | |
| 0.141 | 0.119 | 0.154 | ATPase inhibitor | 0.154 0.095 CID_10257 | CID_10257 | |
| 0.042 | 0.02 | 0.045 | Gonadotropin-releasing hormone receptor antagonist | 0.045 0.018 CID_10257 | CID_10257 | |
| 0.099 | 0.078 | 0.099 | Polo-like kinase-4 inhibitor | |||
| 0.088 | 0.068 | 0.088 | MAO B inhibitor | 0.087 0.068 CID_10257 | ||
| 0.045 | 0.026 | 0.056 | GABA B receptor antagonist | 0.056 0.015 CID_10257 | CID_10257 | |
| 0.141 | 0.123 | 0.175 | Anesthetic general | 0.175 0.09 CID_10257 | CID_10257 | |
| 0.193 | 0.176 | 0.255 | Transcription factor NF kappa B inhibitor | 0.255 0.124 CID_10257 | CID_10257 | |
| 0.095 | 0.077 | 0.137 | Adenylate kinase inhibitor | 0.137 0.032 CID_10257 | CID_10257 | |
| 0.055 | 0.038 | 0.092 | Protein kinase C eta inhibitor | 0.092 0.019 CID_10257 | CID_10257 | |
| 0.08 | 0.063 | 0.08 | Histamine antagonist | |||
| 0.115 | 0.099 | 0.19 | Lipid peroxidase inhibitor | 0.19 0.046 CID_10257 | CID_10257 | |
| 0.069 | 0.053 | 0.069 | Calcium channel L-type blocker | |||
| 0.053 | 0.037 | 0.054 | GABA A receptor antagonist | 0.054 0.036 CID_10257 | CID_10257 | |
| 0.039 | 0.024 | 0.048 | Cholecystokinin B agonist | 0.048 0.017 CID_10257 | CID_10257 | |
| 0.084 | 0.069 | 0.093 | Pim-3 kinase inhibitor | 0.093 0.054 CID_10257 | CID_10257 | |
| 0.097 | 0.082 | 0.16 | DOPA decarboxylase inhibitor | 0.16 0.016 CID_10257 | CID_10257 | |
| 0.043 | 0.028 | 0.055 | Growth hormone release inhibitor | 0.055 0.018 CID_10257 | CID_10257 | |
| 0.068 | 0.053 | 0.068 | Amidase inhibitor | 0.063 0.061 CID_10257 | ||
| 0.083 | 0.068 | 0.083 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.026 | 0.012 | 0.026 | 5 Hydroxytryptamine 4 agonist | |||
| 0.035 | 0.021 | 0.035 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.067 | 0.053 | 0.096 | Protein kinase C beta inhibitor | 0.096 0.015 CID_10257 | CID_10257 | |
| 0.036 | 0.022 | 0.042 | Somatostatin 5 agonist | 0.042 0.017 CID_10257 | CID_10257 | |
| 0.03 | 0.017 | 0.03 | Sigma 1 receptor antagonist | 0.026 0.019 CID_10257 | ||
| 0.141 | 0.128 | 0.166 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.166 0.105 CID_10257 | CID_10257 | |
| 0.03 | 0.017 | 0.03 | Nicotinic alpha4beta2 receptor agonist | 0.027 0.023 CID_10257 | ||
| 0.202 | 0.189 | 0.202 | Ca(v)3.3 blocker | |||
| 0.041 | 0.028 | 0.041 | Neurokinin 1 antagonist | |||
| 0.035 | 0.022 | 0.035 | Growth hormone releasing factor agonist | 0.035 0.021 CID_10257 | ||
| 0.099 | 0.087 | 0.152 | Topoisomerase II inhibitor | 0.152 0.049 CID_10257 | CID_10257 | |
| 0.053 | 0.04 | 0.055 | GABA receptor antagonist | 0.055 0.037 CID_10257 | CID_10257 | |
| 0.079 | 0.068 | 0.079 | Factor XII inhibitor | |||
| 0.138 | 0.127 | 0.178 | Pyruvate kinase inhibitor | 0.178 0.094 CID_10257 | CID_10257 | |
| 0.142 | 0.13 | 0.142 | P-glycoprotein inhibitor | |||
| 0.075 | 0.064 | 0.075 | Acetylcholine nicotinic agonist | 0.071 0.069 CID_10257 | ||
| 0.099 | 0.088 | 0.099 | Nav1.5 sodium channel blocker | |||
| 0.058 | 0.047 | 0.058 | Adrenaline uptake inhibitor | 0.054 0.052 CID_10257 | ||
| 0.037 | 0.027 | 0.037 | Diamine oxidase inhibitor | |||
| 0.051 | 0.041 | 0.051 | Nicotinic alpha3beta2 receptor antagonist | 0.05 0.043 CID_10257 | ||
| 0.061 | 0.051 | 0.061 | Histone deacetylase inhibitor | 0.061 0.053 CID_10257 | ||
| 0.07 | 0.061 | 0.107 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.107 0.034 CID_10257 | CID_10257 | |
| 0.052 | 0.043 | 0.053 | Epithelial sodium channel blocker | 0.053 0.041 CID_10257 | CID_10257 | |
| 0.04 | 0.031 | 0.042 | Neurokinin 2 antagonist | 0.042 0.028 CID_10257 | CID_10257 | |
| 0.068 | 0.059 | 0.068 | Metalloproteinase-9 inhibitor | |||
| 0.168 | 0.159 | 0.186 | Superoxide dismutase inhibitor | 0.186 0.133 CID_10257 | CID_10257 | |
| 0.063 | 0.054 | 0.242 | Phenylalanine 4-hydroxylase inhibitor | 0.242 0.005 CID_10257 | CID_10257 | |
| 0.02 | 0.011 | 0.021 | Somatostatin 3 agonist | 0.021 0.008 CID_10257 | CID_10257 | |
| 0.098 | 0.091 | 0.117 | TRPA1 agonist | 0.117 0.062 CID_10257 | CID_10257 | |
| 0.16 | 0.153 | 0.259 | Antioxidant | 0.259 0.079 CID_10257 | CID_10257 | |
| 0.092 | 0.085 | 0.092 | EphA2 antagonist | |||
| 0.099 | 0.092 | 0.126 | Acetylcholine muscarinic antagonist | 0.126 0.061 CID_10257 | CID_10257 | |
| 0.164 | 0.157 | 0.164 | Calpain inhibitor | 0.163 0.159 CID_10257 | ||
| 0.049 | 0.043 | 0.057 | Protein kinase C epsilon inhibitor | 0.057 0.033 CID_10257 | CID_10257 | |
| 0.017 | 0.011 | 0.017 | Cholecystokinin A agonist | 0.014 0.013 CID_10257 | ||
| 0.019 | 0.013 | 0.019 | Cholecystokinin agonist | 0.016 0.015 CID_10257 | ||
| 0.083 | 0.077 | 0.083 | Polo-like kinase-1 inhibitor | |||
| 0.142 | 0.138 | 0.154 | EphB2 antagonist | 0.154 0.126 CID_10257 | CID_10257 | |
| 0.095 | 0.09 | 0.095 | CDC-like kinase 3 inhibitor | |||
| 0.058 | 0.053 | 0.059 | Neutrophil collagenase inhibitor | 0.059 0.051 CID_10257 | CID_10257 | |
| 0.044 | 0.04 | 0.044 | Metalloproteinase-3 inhibitor | |||
| 0.079 | 0.075 | 0.079 | Fibroblast growth factor 1 antagonist | |||
| 0.192 | 0.189 | 0.198 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.198 0.172 CID_10257 | CID_10257 | |
| 0.051 | 0.048 | 0.051 | Dopamine uptake inhibitor | |||
| 0.112 | 0.109 | 0.114 | Vanilloid 1 agonist | 0.114 0.104 CID_10257 | CID_10257 | |
| 0.017 | 0.015 | 0.018 | Growth hormone release promoting | 0.018 0.015 CID_10257 | CID_10257 | |
| 0.133 | 0.131 | 0.133 | Clk dual-specificity kinase inhibitor | |||
| 0.049 | 0.047 | 0.049 | Beta tubulin antagonist | |||
| 0.026 | 0.025 | 0.042 | Somatostatin 5 antagonist | 0.042 0.017 CID_10257 | CID_10257 | |
| 0.029 | 0.028 | 0.029 | Growth hormone secretagogue receptor agonist | |||
| 0.013 | 0.013 | 0.019 | Somatostatin 2 agonist | 0.019 0.007 CID_10257 | CID_10257 | |
| 0.075 | 0.077 | 0.076 | Falcipain 2 inhibitor | 0.076 0.075 CID_10257 | CID_10257 | |
| 0.076 | 0.079 | 0.078 | Falcipain inhibitor | 0.078 0.077 CID_10257 | CID_10257 | |
| 0.051 | 0.053 | 0.059 | Acetylcholine M2 receptor antagonist | 0.059 0.045 CID_10257 | CID_10257 | |
| 0.013 | 0.016 | 0.015 | NMDA receptor phencyclidine site antagonist | 0.015 0.01 CID_10257 | CID_10257 | |
| 0.031 | 0.035 | 0.037 | Protein kinase C beta I inhibitor | 0.037 0.014 CID_10257 | CID_10257 | |
| 0.019 | 0.024 | 0.026 | Somatostatin 4 antagonist | 0.026 0.014 CID_10257 | CID_10257 | |
| 0.02 | 0.024 | 0.048 | Somatostatin 2 antagonist | 0.048 0.016 CID_10257 | CID_10257 | |
| 0.047 | 0.052 | 0.049 | Vanilloid 2 antagonist | 0.049 0.045 CID_10257 | CID_10257 | |
| 0.015 | 0.021 | 0.02 | Somatostatin 3 antagonist | 0.02 0.014 CID_10257 | CID_10257 | |
| 0.016 | 0.022 | 0.029 | Estrogen-related receptor gamma agonist | 0.029 0.004 CID_10257 | CID_10257 | |
| 0.083 | 0.089 | 0.111 | Mediator release inhibitor | 0.111 0.057 CID_10257 | CID_10257 | |
| 0.018 | 0.025 | 0.029 | Beta 1 adrenoreceptor agonist | 0.029 0.009 CID_10257 | CID_10257 | |
| 0.117 | 0.123 | 0.148 | Cyclin-dependent kinase 8 inhibitor | 0.148 0.081 CID_10257 | CID_10257 | |
| 0.091 | 0.1 | 0.113 | Alkylator | 0.113 0.075 CID_10257 | CID_10257 | |
| 0.042 | 0.051 | 0.07 | Topoisomerase II beta inhibitor | 0.07 0.017 CID_10257 | CID_10257 | |
| 0.07 | 0.08 | 0.103 | MAP kinase kinase 7 inhibitor | 0.103 0.01 CID_10257 | CID_10257 | |
| 0.024 | 0.035 | 0.037 | Estrogen-related receptor gamma antagonist | 0.037 0.007 CID_10257 | CID_10257 | |
| 0.016 | 0.028 | 0.02 | Leukotriene B4 receptor 2 antagonist | 0.02 0.018 CID_10257 | CID_10257 | |
| 0.027 | 0.039 | 0.048 | Estrogen-related receptor beta antagonist | 0.048 0.006 CID_10257 | CID_10257 | |
| 0.098 | 0.11 | 0.101 | Sphingosine 1-phosphate receptor 2 agonist | 0.101 0.099 CID_10257 | CID_10257 | |
| 0.035 | 0.048 | 0.051 | Geranyltranstransferase inhibitor | 0.051 0.021 CID_10257 | CID_10257 | |
| 0.124 | 0.137 | 0.156 | MAP kinase kinase 4 inhibitor | 0.156 0.052 CID_10257 | CID_10257 | |
| 0.075 | 0.088 | 0.086 | Protein kinase C mu inhibitor | 0.086 0.073 CID_10257 | CID_10257 | |
| 0.032 | 0.046 | 0.04 | Endothelin-converting enzyme inhibitor | 0.04 0.038 CID_10257 | CID_10257 | |
| 0.085 | 0.101 | 0.153 | Chelator | 0.153 0.034 CID_10257 | CID_10257 | |
| 0.029 | 0.045 | 0.041 | Dopamine D5 antagonist | 0.041 0.031 CID_10257 | CID_10257 | |
| 0.005 | 0.022 | 0.013 | Beta 3 adrenoreceptor agonist | 0.013 0.007 CID_10257 | CID_10257 | |
| 0.044 | 0.063 | 0.05 | Bombesin 3 receptor antagonist | 0.05 0.047 CID_10257 | CID_10257 | |
| 0.065 | 0.083 | 0.102 | Carbonic anhydrase VI inhibitor | 0.102 0.038 CID_10257 | CID_10257 | |
| 0.08 | 0.099 | 0.09 | Nav1.1 sodium channel blocker | 0.09 0.08 CID_10257 | CID_10257 | |
| 0.063 | 0.082 | 0.087 | Macrophage migration inhibitory factor inhibitor | 0.087 0.044 CID_10257 | CID_10257 | |
| 0.131 | 0.152 | 0.136 | Cyclin-dependent kinase 3 inhibitor | 0.136 0.135 CID_10257 | CID_10257 | |
| 0.042 | 0.064 | 0.049 | Pim-2 kinase inhibitor | 0.049 0.048 CID_10257 | CID_10257 | |
| 0.132 | 0.155 | 0.164 | Death-associated protein kinase 2 inhibitor | 0.164 0.078 CID_10257 | CID_10257 | |
| 0.183 | 0.206 | 0.236 | Apoptosis antagonist | 0.236 0.142 CID_10257 | CID_10257 | |
| 0.043 | 0.067 | 0.069 | Acetylcholine M3 receptor antagonist | 0.069 0.032 CID_10257 | CID_10257 | |
| 0.231 | 0.255 | 0.261 | 5 Hydroxytryptamine release inhibitor | 0.261 0.213 CID_10257 | CID_10257 | |
| 0.032 | 0.056 | 0.111 | NMDA 2A receptor antagonist | 0.111 0.011 CID_10257 | CID_10257 | |
| 0.056 | 0.081 | 0.091 | Topoisomerase II alpha inhibitor | 0.091 0.045 CID_10257 | CID_10257 | |
| 0.09 | 0.117 | 0.147 | Aldehyde dehydrogenase inhibitor | 0.147 0.049 CID_10257 | CID_10257 | |
| 0.12 | 0.153 | 0.153 | MAP kinase kinase 2 inhibitor | 0.153 0.118 CID_10257 | CID_10257 | |
| 0.082 | 0.115 | 0.102 | Cholesterol synthesis inhibitor | 0.102 0.084 CID_10257 | CID_10257 | |
| 0.061 | 0.094 | 0.071 | Interferon agonist | 0.071 0.068 CID_10257 | CID_10257 | |
| 0.049 | 0.083 | 0.064 | Check point kinase 1 inhibitor | 0.064 0.053 CID_10257 | CID_10257 | |
| 0.024 | 0.06 | 0.033 | Protein kinase C beta II inhibitor | 0.033 0.02 CID_10257 | CID_10257 | |
| 0.128 | 0.168 | 0.154 | Catenin beta inhibitor | 0.154 0.096 CID_10257 | CID_10257 | |
| 0.045 | 0.086 | 0.065 | CDC25B inhibitor | 0.065 0.043 CID_10257 | CID_10257 | |
| 0.075 | 0.117 | 0.097 | Interleukin 12 antagonist | 0.097 0.059 CID_10257 | CID_10257 | |
| 0.112 | 0.154 | 0.143 | Dual specificity phosphatase inhibitor | 0.143 0.103 CID_10257 | CID_10257 | |
| 0.116 | 0.158 | 0.135 | Interleukin 6 antagonist | 0.135 0.114 CID_10257 | CID_10257 | |
| 0.013 | 0.056 | 0.021 | Dopamine D1 agonist | 0.021 0.019 CID_10257 | CID_10257 | |
| 0.016 | 0.068 | 0.027 | Thyroid hormone agonist | 0.027 0.017 CID_10257 | CID_10257 | |
| 0.02 | 0.073 | 0.034 | Opioid delta receptor agonist | 0.034 0.027 CID_10257 | CID_10257 | |
| 0.049 | 0.103 | 0.09 | Analgesic, opioid | 0.09 0.038 CID_10257 | CID_10257 | |
| 0.035 | 0.091 | 0.054 | CXC chemokine 4 receptor antagonist | 0.054 0.047 CID_10257 | CID_10257 | |
| 0.12 | 0.177 | 0.141 | Death-associated protein kinase 3 inhibitor | 0.141 0.138 CID_10257 | CID_10257 | |
| 0.033 | 0.091 | 0.049 | Dopamine beta hydroxylase inhibitor | 0.049 0.032 CID_10257 | CID_10257 | |
| 0.066 | 0.125 | 0.142 | GABA C receptor agonist | 0.142 0.037 CID_10257 | CID_10257 | |
| 0.022 | 0.081 | 0.065 | Dopamine D5 agonist | 0.065 0.01 CID_10257 | CID_10257 | |
| 0.148 | 0.207 | 0.212 | DNA synthesis inhibitor | 0.212 0.105 CID_10257 | CID_10257 | |
| 0.069 | 0.128 | 0.09 | Bile acid receptor antagonist | 0.09 0.073 CID_10257 | CID_10257 | |
| 0.057 | 0.116 | 0.111 | Opioid antagonist | 0.111 0.04 CID_10257 | CID_10257 | |
| 0.122 | 0.185 | 0.221 | Immunostimulant | 0.221 0.109 CID_10257 | CID_10257 | |
| 0.066 | 0.13 | 0.095 | Lanosterol 14 alpha demethylase inhibitor | 0.095 0.064 CID_10257 | CID_10257 | |
| 0.025 | 0.089 | 0.046 | Opioid mu receptor agonist | 0.046 0.032 CID_10257 | CID_10257 | |
| 0.023 | 0.088 | 0.053 | Carbonic anhydrase VB inhibitor | 0.053 0.042 CID_10257 | CID_10257 | |
| 0.052 | 0.12 | 0.153 | NMDA receptor antagonist | 0.153 0.023 CID_10257 | CID_10257 | |
| 0.056 | 0.126 | 0.086 | Estrogen receptor alpha antagonist | 0.086 0.04 CID_10257 | CID_10257 | |
| 0.04 | 0.111 | 0.07 | Na+ K+ transporting ATPase inhibitor | 0.07 0.06 CID_10257 | CID_10257 | |
| 0.144 | 0.215 | 0.186 | RNA-directed DNA polymerase inhibitor | 0.186 0.122 CID_10257 | CID_10257 | |
| 0.04 | 0.114 | 0.055 | Heat shock protein 90 beta antagonist | 0.055 0.048 CID_10257 | CID_10257 | |
| 0.086 | 0.161 | 0.119 | Transcription factor STAT6 inhibitor | 0.119 0.061 CID_10257 | CID_10257 | |
| 0.095 | 0.17 | 0.13 | Arachidonic acid antagonist | 0.13 0.113 CID_10257 | CID_10257 | |
| 0.119 | 0.196 | 0.133 | Ca2+-transporting ATPase inhibitor | 0.133 0.102 CID_10257 | CID_10257 | |
| 0.022 | 0.101 | 0.057 | NMDA receptor subunit 3B antagonist | 0.057 0.02 CID_10257 | CID_10257 | |
| 0.031 | 0.112 | 0.123 | NMDA 2 receptor antagonist | 0.123 0.023 CID_10257 | CID_10257 | |
| 0.065 | 0.146 | 0.084 | Hematopoietic | 0.084 0.062 CID_10257 | CID_10257 | |
| 0.139 | 0.226 | 0.199 | 12-Lipoxygenase inhibitor | 0.199 0.153 CID_10257 | CID_10257 | |
| 0.161 | 0.248 | 0.255 | Sodium/bile acid cotransporter inhibitor | 0.255 0.123 CID_10257 | CID_10257 | |
| 0.086 | 0.175 | 0.162 | Angiogenesis stimulant | 0.162 0.115 CID_10257 | CID_10257 | |
| 0.03 | 0.123 | 0.057 | Androgen agonist | 0.057 0.045 CID_10257 | CID_10257 | |
| 0.062 | 0.155 | 0.078 | D-Ala-D-Ala ligase inhibitor | 0.078 0.076 CID_10257 | CID_10257 | |
| 0.034 | 0.128 | 0.073 | Histidine decarboxylase inhibitor | 0.073 0.048 CID_10257 | CID_10257 | |
| 0.13 | 0.225 | 0.186 | MAP-kinase-activated kinase 5 inhibitor | 0.186 0.123 CID_10257 | CID_10257 | |
| 0.02 | 0.116 | 0.047 | Opioid agonist | 0.047 0.043 CID_10257 | CID_10257 | |
| 0.016 | 0.113 | 0.041 | Oxytocin agonist | 0.041 0.031 CID_10257 | CID_10257 | |
| 0.026 | 0.132 | 0.075 | Opioid mu receptor antagonist | 0.075 0.043 CID_10257 | CID_10257 | |
| 0.07 | 0.176 | 0.118 | Thrombolytic | 0.118 0.112 CID_10257 | CID_10257 | |
| 0.021 | 0.134 | 0.065 | Opioid delta receptor antagonist | 0.065 0.043 CID_10257 | CID_10257 | |
| 0.046 | 0.164 | 0.079 | Opioid kappa receptor antagonist | 0.079 0.059 CID_10257 | CID_10257 | |
| 0.013 | 0.133 | 0.036 | NMDA receptor subunit 3A antagonist | 0.036 0.028 CID_10257 | CID_10257 | |
| 0.053 | 0.177 | 0.091 | Cystathionine beta-synthase inhibitor | 0.091 0.089 CID_10257 | CID_10257 | |
| 0.017 | 0.148 | 0.057 | NMDA 2C receptor antagonist | 0.057 0.05 CID_10257 | CID_10257 | |
| 0.066 | 0.202 | 0.136 | Estrogen antagonist | 0.136 0.031 CID_10257 | CID_10257 | |
| 0.068 | 0.205 | 0.124 | Interleukin 4 antagonist | 0.124 0.08 CID_10257 | CID_10257 | |
| 0.024 | 0.164 | 0.05 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.05 0.043 CID_10257 | CID_10257 | |
| 0.102 | 0.249 | 0.15 | Phospholipase C inhibitor | 0.15 0.106 CID_10257 | CID_10257 | |
| 0.097 | 0.248 | 0.166 | Neurotrophic factor enhancer | 0.166 0.115 CID_10257 | CID_10257 | |
| 0.038 | 0.198 | 0.083 | Aminopeptidase B inhibitor | 0.083 0.079 CID_10257 | CID_10257 | |
| 0.016 | 0.184 | 0.038 | AMPA 4 receptor antagonist | 0.038 0.031 CID_10257 | CID_10257 | |
| 0.034 | 0.213 | 0.091 | Alcohol dehydrogenase inhibitor | 0.091 0.063 CID_10257 | CID_10257 | |
| 0.022 | 0.224 | 0.07 | Porphobilinogen synthase inhibitor | 0.07 0.056 CID_10257 | CID_10257 | |
| 0.034 | 0.262 | 0.123 | Creatine kinase inhibitor | 0.123 0.039 CID_10257 | CID_10257 | |
| 0.038 | 0.29 | 0.115 | Estrogen receptor beta antagonist | 0.115 0.038 CID_10257 | CID_10257 | |
| 0.105 | 0.39 | 0.169 | Peptidyltransferase inhibitor | 0.169 0.148 CID_10257 | CID_10257 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |